このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Acute Effects of Inspiratory Muscle Warm-Up on Inspiratory Muscle Strength During Aerobic and Anaerobic Exercise in Athletes (IMW-AE)

2026年11月8日 更新者:Mehmet İsmail TOSUN、Hitit University

アスリートにおける有酸素運動および無酸素運動中の吸息筋強度に対する吸息筋ウォームアップの急性効果

Inspiratory muscle warm-up (IMW) is a specific pre-exercise breathing intervention designed to prepare the respiratory muscles before physical activity and potentially enhance exercise performance. Previous research suggests that IMW may acutely improve inspiratory muscle function; however, the duration of these effects during exercise and their responses under different exercise intensities remain unclear. Furthermore, placebo-controlled comparisons are limited in the current literature.

The purpose of this study is to investigate the acute effects of inspiratory muscle warm-up on inspiratory muscle strength during aerobic and anaerobic exercise in trained athletes. The study will compare three experimental conditions: a standardized inspiratory muscle warm-up protocol, a placebo breathing warm-up, and a control condition without respiratory warm-up.

In this repeated-measures interventional study, trained athletes aged 14-30 years will complete three experimental sessions in randomized order. The active intervention consists of inspiratory muscle warm-up performed at 40% of maximal inspiratory pressure (MIP). The placebo condition includes a low-resistance breathing protocol designed to mimic the intervention without providing a meaningful training stimulus. The control condition involves exercise performed without respiratory warm-up.

Participants will perform treadmill exercise at intensity levels representing aerobic and anaerobic workloads, defined according to percentage of maximal heart rate. Inspiratory muscle strength (MIP) will be assessed at baseline, immediately after the warm-up protocols, and periodically during exercise to evaluate time-dependent changes.

The primary objective is to determine how long the acute increase in inspiratory muscle strength is maintained during exercise and to compare responses between aerobic and anaerobic athletes across the three conditions. The findings may provide evidence-based guidance for integrating respiratory muscle warm-up strategies into sport-specific preparation routines.

調査の概要

状態

完了

条件

介入・治療

詳細な説明

Inspiratory muscle warm-up (IMW) has emerged as a non-pharmacological pre-exercise strategy aimed at enhancing respiratory muscle readiness prior to physical activity. The inspiratory muscles, particularly the diaphragm and accessory respiratory muscles, play a critical role in meeting increased ventilatory demands during exercise. Acute respiratory muscle fatigue has been associated with reduced performance through mechanisms such as altered ventilatory efficiency and activation of the respiratory muscle metaboreflex, which may redistribute blood flow away from locomotor muscles. While previous studies have reported beneficial acute effects of IMW on respiratory and performance parameters, the temporal characteristics of these effects during ongoing exercise remain insufficiently understood.

Existing research has primarily focused on pre- and post-intervention comparisons, often evaluating inspiratory muscle strength immediately following IMW without assessing how long these acute improvements persist during exercise. Furthermore, the influence of exercise intensity domains and athlete specialization (aerobic vs. anaerobic disciplines) on the duration of IMW-induced effects has not been systematically investigated. Another limitation of prior studies is the limited use of placebo-controlled designs, which are important for distinguishing physiological effects from expectancy or psychological influences associated with warm-up interventions.

The present study is designed as a repeated-measures interventional investigation to evaluate the acute time course of inspiratory muscle strength responses following inspiratory muscle warm-up under different exercise conditions. Each participant will complete three experimental sessions, including: (1) an active inspiratory muscle warm-up protocol performed at a standardized relative intensity, (2) a placebo breathing warm-up designed to mimic the intervention without providing a meaningful physiological load, and (3) a control condition without respiratory warm-up. The order of conditions will be counterbalanced to minimize order effects.

Exercise trials will involve treadmill running performed at predefined intensity domains representing aerobic and anaerobic workloads based on individual maximal heart rate. Inspiratory muscle strength will be measured repeatedly throughout exercise to identify the time-dependent decline relative to baseline and post-warm-up levels. This design allows examination of both immediate and sustained effects of respiratory muscle preparation strategies.

By comparing responses between athletes from predominantly aerobic and anaerobic sports backgrounds, the study seeks to explore whether differences in energy system utilization, muscle fiber composition, and ventilatory demands influence the effectiveness and duration of inspiratory muscle warm-up. The findings may contribute to a more precise understanding of respiratory muscle preparation and support evidence-based integration of breathing-specific warm-up strategies into athletic training and competition routines.

研究の種類

介入

入学 (実際)

37

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Çorum
      • Çorum、Çorum、トルコ(Türkiye)、19030
        • Hitit University Faculty of Sport Sciences, Exercise Physiology Laboratory

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~35年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age between 18 and 35 years.
  • Regular participation in organized sports training for at least 4 years.
  • Engaged in predominantly aerobic or anaerobic sports disciplines.
  • Training frequency of at least 3 sessions per week.
  • No known cardiopulmonary disease affecting respiratory function.
  • Ability to safely perform maximal effort treadmill exercise.
  • No respiratory illness within the last 12 weeks.
  • Willingness to comply with study procedures.
  • Provision of written informed consent (and parental consent for minors where applicable).

Exclusion Criteria:

  • History of asthma, chronic obstructive pulmonary disease (COPD), or other respiratory disorders.
  • Age below 18 years or above 35 years.
  • Orthopedic injury or condition limiting running ability.
  • Participation in inspiratory muscle training within the last 12 months.
  • Use of medications affecting respiratory or cardiovascular function.
  • Active smoking.
  • Failure to provide informed consent.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:4倍

武器と介入

参加者グループ / アーム
介入・治療
実験的:Inspiratory Muscle Warm-Up (40% MIP)

Participants perform a standardized inspiratory muscle warm-up using a breathing resistance device set at 40% of maximal inspiratory pressure (MIP) prior to exercise testing. The protocol consists of resisted inspiratory efforts designed to acutely activate the respiratory muscles before aerobic or anaerobic exercise.

A standardized inspiratory muscle warm-up performed using a breathing resistance device set at 40% of maximal inspiratory pressure (MIP). Participants perform resisted inspiratory efforts prior to exercise to acutely activate respiratory muscles.

プラセボコンパレーター:Placebo Breathing Warm-Up (15% MIP)

Participants perform a placebo breathing warm-up using the same device and procedures as the active intervention, but with resistance set at 15% of maximal inspiratory pressure (MIP). This low-resistance protocol is intended to mimic the intervention while minimizing meaningful physiological loading.

A sham breathing warm-up performed using the same device and breathing pattern as the active intervention but with resistance set at 15% of maximal inspiratory pressure (MIP), intended to minimize physiological loading while maintaining procedural similarity.

介入なし:Control (No Respiratory Warm-Up)

Participants complete the exercise protocol without any inspiratory muscle warm-up prior to testing.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Time to Decline in Maximal Inspiratory Pressure (MIP) During Exercise
時間枠:From exercise onset until the time of MIP decline during a single acute exercise testing session (up to 30 minutes).

Time (minutes) until maximal inspiratory pressure (MIP) decreases below baseline or post-warm-up levels during aerobic and anaerobic exercise following inspiratory muscle warm-up, placebo breathing warm-up, or control conditions.

From exercise onset until the time of MIP decline during a single acute exercise testing session (up to 30 minutes).

二次結果の測定

結果測定
メジャーの説明
時間枠
Acute Change in Maximal Inspiratory Pressure After Warm-Up
時間枠:From exercise onset until MIP declines below baseline or post-warm-up values, assessed at minutes 2, 4, 6, 8, and 10, then at minutes 14, 18, 22, 26, and 30 (up to 30 minutes).

Difference between baseline MIP and immediate post-warm-up MIP across experimental conditions.

From exercise onset until MIP declines below baseline or post-warm-up values, assessed at minutes 2, 4, 6, 8, and 10, then at minutes 14, 18, 22, 26, and 30 (up to 30 minutes).
Repeated MIP Measurements During Exercise
時間枠:Every 2 minutes during exercise.

Periodic maximal inspiratory pressure values measured at predefined intervals during treadmill exercise.

Every 2 minutes during exercise.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年2月25日

一次修了 (実際)

2026年5月20日

研究の完了 (実際)

2026年5月20日

試験登録日

最初に提出

2026年2月18日

QC基準を満たした最初の提出物

2026年2月28日

最初の投稿 (実際)

2026年3月3日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月12日

QC基準を満たした最後の更新が送信されました

2026年11月8日

最終確認日

2026年2月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2025-39

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified individual participant data (IPD) underlying the results reported in publications, including maximal inspiratory pressure (MIP) measurements, demographic variables, exercise responses, and related outcome variables, will be made available through Figshare following publication of the main study results. A data dictionary and relevant methodological documentation will be provided to facilitate appropriate interpretation of the dataset. Data sharing will comply with institutional ethics approval and applicable data protection regulations.

IPD 共有時間枠

De-identified individual participant data will be made publicly available through Figshare beginning 6 months after publication of the primary results and will remain accessible for at least 5 years, subject to institutional ethics approval and applicable data protection requirements.

IPD 共有アクセス基準

De-identified individual participant data and supporting documents will be available to qualified researchers upon reasonable request. Researchers must submit a proposal outlining the research objectives, analysis plan, and intended use of the data. Requests will be reviewed by the principal investigator to ensure scientific validity, ethical compliance, and alignment with the original informed consent and institutional policies. Data sharing will require the signing of a data use agreement, and access will be provided for non-commercial scientific research purposes only. Data will be shared in anonymized form through secure electronic transfer.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。